All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date, and reported results | 2004-005078-22 | Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions in p... | bad-data | |
Reported results | 2005-000040-85 | Erbitux Monotherapie bei Patienten mit lokoregional nicht behandelbarem Hepatozellulären Karzinom | 2008-01-31 | due-trials |
Reported results | 2005-000774-46 | BOne marrOw transfer to enhance ST-elevation infarct regeneration-2 | 2016-06-24 | due-trials |
Reported results Terminated | 2005-001411-22 | Serotonin-Transporter Binding in Tourette-Syndrome and Obsessive-Compulsive Disorder before and during Treatment with SRI: a I-123-ADAM-SPECT-Study | 2013-07-31 | due-trials |
Reported results | 2005-002634-35 | Single centre, prospective, comparative, open-label, randomised study to evaluate the efficacy and tolerability of the combination of Moxifloxacin plus Metronidazole versus Piperacillin/Tazobactam for... | 2012-07-07 | due-trials |
Reported results | 2006-000673-30 | Placebo kontrollierte Phase II Studie zur Therapie des fortgeschrittenen HCC mit Viscum fraxini | 2016-01-20 | due-trials |
Reported results | 2006-001407-11 | A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolon and switch to low-dose ciclosporine A and everolimus without steroids in the prevention... | 2010-05-18 | due-trials |
Reported results | 2006-002546-11 | Offene Phase IIIb Studie zur Elimination von CD4+CD25+ regulatorischen T-Zellen bei Patienten mit fortgeschrittenem HCC durch die Gabe von Cyclophosphamid | 2008-11-24 | due-trials |
Reported results | 2006-002938-38 | EFFECT OF ERYTHROPOIETIN ON RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION | 2009-05-31 | due-trials |
Not reported | 2006-002962-20 | Elimination of the preleukemic clone in children with Down syndrome and transient myeloproloferative disorder (TMD) to prevent AML - Model of leukemia prevention | 2015-02-08 | due-trials |
Reported results Terminated | 2007-000242-12 | Monozentrische, prospektiv durchgeführte Studie zur Untersuchung der Pharmakokinetik von Voriconazol nach einmaliger und wiederholter Gabe von 2x4mg/kg pro Tag bei niereninsuffizienten Patienten mit G... | 2009-09-08 | due-trials |
Reported results Terminated | 2007-000506-78 | Monozentrische, prospektive, offene Studie zur Untersuchung der „steady state“-Pharmakokinetik von Tigecyclin im Plasma, im ELF und in Alveolarmakrophagen bei Intensivpatienten mit tiefer Atemwegsinfe... | 2008-07-22 | due-trials |
Reported results | 2007-000517-10 | Monozentrische, prospektiv durchgeführte Studie zur Untersuchung der „steady state“ - Pharmakokinetik von Caspofungin im Plasma, im ELF und in Alveolarmakrophagen bei beatmeten Intensivpatienten mit n... | 2008-07-22 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2007-001200-20 | A Multicenter, Randomized Phase II Trial Assessing the Activity of Gemcitabine – Oxaliplatin Chemotherapy Alone or in Combination with Cetuximab in Patients with Advanced Biliary Cancer | 2010-07-27 | bad-data |
Reported results | 2007-003710-34 | EFFECT OF BROMOCRIPTINE ON LEFT VENTRICULAR FUNCTION IN WOMEN WITH PERIPARTUM CARDIOMYOPATHY | 2016-03-07 | due-trials |
Not reported | 2007-004517-34 | Allogeneic stem cell transplantation for children, adolescents and young adults with relapsed or refractory AML | 2021-02-24 | due-trials |
Reported results | 2007-004611-61 | Prospektive, randomisierte, monozentrische 2-armige Studie zum Einsatz von Daptomycin in der antibiotischen Prophylaxe von sternalen Wundinfektionen nach medianer Sternotomie | 2012-03-12 | due-trials |
Reported results Terminated | 2007-005503-17 | Randomized multicenter double-blind study of phase III in patients after kidney transplantation with an acute cellular rejection with a tubulointerstinal component in kidney transplant with histologic... | 2016-05-02 | due-trials |
Reported results Terminated | 2008-000706-36 | Optimization of treatment for patients with chronic hepatitis C infected with HCV-genotype 2 or 3: 12 vs. 24 weeks of treatment extension for patients without rapid virological response | 2013-08-05 | due-trials |
Reported results | 2008-000766-23 | Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study- | 2010-08-25 | due-trials |
Reported results Terminated | 2008-002338-31 | Prospektive randomisierte Phase II Studie zur Behandlung von Patienten mit fortgeschrittenem hormonrefraktären Prostatakarzinom mittels LHRH-Analoga und Somatostatin-Analoga unter Berücksichtigung der... | 2011-06-30 | due-trials |
Reported results | 2008-005433-30 | Taxotere-Enoxaparin-(ENOXA)-Studie: 1st-Line Docetaxel-Platin Chemotherapie alleine oder in Kombination mit Enoxaparin bei Patienten mit lokal fortgeschrittenem oder metastasiertem nicht-kleinzelligem... | 2011-03-28 | due-trials |
Reported results | 2008-005560-13 | A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interfeorn-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis- The Hep... | 2017-08-02 | due-trials |
Reported results | 2008-005862-30 | Pre-emptive therapy of acute graft versus host disease according to specific proteomic patterns after allogeneic hematopoietic stem cell transplantation. | 2015-12-07 | due-trials |
Reported results Terminated | 2008-005925-12 | Polyomavirus BK nephropathy after renal transplantation: Randomized clinical trial to demonstrate that switching to mTOR inhibitor is more effective than a reduction of immunosuppressive therapy | 2020-07-23 | due-trials |
Reported results | 2008-005976-28 | Prevention of HBV reinfection after liver transplantation using entecavir monotherapy after short-term HBIg administration: A pilot study Version 1.2 2008-09-11 Amendment 2 2009-07-07 | 2015-10-26 | due-trials |
Reported results Terminated | 2009-011324-60 | Prospective randomized trial to compare a twice daily to a once daily administration of the Tacrolimus in lung transplanted patients | 2012-07-02 | due-trials |
Reported results | 2009-012436-32 | A multicenter, randomized, open-labeled study to steer immunsuppressive and antiviral therapy by measurement of virus- (CMV, ADV, HSV) specific T cells in addition to determination of trough levels of... | 2019-03-26 | due-trials |
Reported results | 2009-014383-18 | A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer | 2014-03-14 | due-trials |
Reported results | 2009-014396-43 | A single arm, open-label multicenter phase II trial of temsirolimus in patients with relapsed/ recurrent squamous cell cancer of the Head and Neck (HNSCC) | 2012-03-12 | due-trials |
Reported results | 2009-015125-36 | Clostridium botulinum Typ A Neurotoxinkomplex zur adjuvanten Behandlung von depressiven Störungen – Eine randomisierte, kontrollierte Pilotstudie | 2011-12-31 | due-trials |
Reported results | 2009-017052-27 | A Phase II Study to Evaluate the Immunogenicity, Safety and Tolerability of a H1N1 Influenza Vaccine in Immunocompromised Adults Who Have Undergone Solid Organ Transplantation or Bone Marrow Transplan... | 2011-04-30 | due-trials |
Not reported | 2010-018850-11 | Panitumumab in combination with cisplatin/gemcitabine chemotherapy in patients with cholangiocarcinomas - a randomized clinical phase II study - PiCCA Study | 2015-12-15 | due-trials |
Listed as ongoing, but also has a completion date | 2010-018980-41 | International randomized phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia | 2020-08-01 | bad-data |
Exempt | 2010-021719-18 | Phase I/II study on cytarabine and idarubicine combined with escalating doses of clofarabine as induction therapy in patients with acute myeloid leukemia and high risk for induction failure (CIARA) | 2016-02-23 | not-yet-due |
Reported results | 2010-021944-17 | Randomized, Multi-centre, Phase II Trial to compare the Event-Free Survival of Clofarabine / Ara-C (ClAraC) or of FLAMSA Treatment in Patients with High Risk AML or Advanced MDS scheduled for Allogene... | 2017-05-15 | due-trials |
Reported results | 2010-022871-78 | A Phase II Study to Evaluate the Immunogenicity, Safety and Tolerability of a Seasonal Influenza Vaccine including H1N1 in Immunocompromised Adults Who Have Undergone Solid Organ Transplantation or Bo... | 2012-03-06 | due-trials |
Reported results | 2011-004168-30 | A randomized phase II trial comparing pazopanib with doxorubicin as first line treatment in elderly patients with metastatic or advanced soft tissue sarcoma | 2017-03-10 | due-trials |
Reported results | 2012-001352-19 | BE-RELACs-Trial: Biomarkers Explaining RELevance of ACute Rejections | 2017-06-06 | due-trials |
Reported results Terminated | 2012-003234-16 | Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD – The ABACOPD Study | 2019-06-05 | due-trials |
Reported results Terminated | 2012-005002-22 | ACEMg mediated hearing preservation in cochlear implant patients receiving different electrode lengths | 2016-06-15 | due-trials |
Reported results | 2013-001081-42 | Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection with Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study | 2016-06-13 | due-trials |
Reported results | 2013-002825-52 | Single-center, open-label, single-arm Phase IIa study in kidney transplant patients with acute T-cell-mediated rejection in renal transplant according to Banff criteria (class IA and IB) without (stag... | 2015-06-19 | due-trials |
Ongoing | 2013-005326-38 | A multicenter, randomized, double-blind, placebo-controlled study to demonstrate that digitoxin reduces a composite of overall mortality and hospitalization for worsening heart failure in patients wit... | not-yet-due | |
Reported results Terminated | 2014-003313-28 | SGLT2 inhibition with empagliflozin in patients with type 2 diabetes mellitus: Influences on left ventricular mass, function, and cardiac lipid content (EMPATROPHY) | 2018-06-29 | due-trials |
Reported results | 2015-000749-21 | Botulinumtoxin A for emotional stabilization in borderline personality disorder Botulinumtoxin A zur emotionalen Stabilisierung bei der Borderline-Persönlichkeitsstörung | 2019-05-10 | due-trials |
Reported results | 2016-000564-42 | A randomized multi-centre double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders (CANNA-TICS) Randomisiert... | 2020-11-20 | due-trials |
Reported results Terminated | 2016-000825-38 | SGLT2-inhibition with Empagliflozin reduces progression of diabetic retinopathy in patients with high risk of diabetic macular edema (The SUPER-Trial) | 2018-09-18 | due-trials |
Reported results | 2016-005100-26 | A pilot Study to explore safety, tolerability and efficacy of ORal IrON supplementation with ferric maltol in treating iron deficiency in patients with pulmonary hypertension and iron deficiency anemi... | 2020-03-19 | due-trials |
Reported results | 2016-005101-39 | A phase IV study to explore the safety of ORal IrON supplementation with ferric maltol in treating iron deficiency in patients with heart failure carrying Left Ventricular Assist Devices (ORION-LVAD-1... | 2019-11-29 | due-trials |
Reported results Terminated | 2017-000394-36 | Influences of angiotensin-neprilysin inhibition with Sacubitril/Valsartan (ENTRESTO®) on centrally generated sympathetic activity in heart failure patients | 2018-09-06 | due-trials |
Reported results | 2017-000403-24 | HepNet pilot trial: Multicenter trial for the treatment of chronic hepatitis E with sofosbuvir (SofE) | 2019-02-18 | due-trials |
Reported results | 2018-003474-27 | Multicenter trial for the treatment of acute Hepatitis C for 8 weeks with Sofosbuvir/Velpatasvir fix dose combination - The HepNet Acute HCV-V study | 2021-06-08 | due-trials |
Reported results Terminated | 2020-001936-86 | A prospective, randomized, open label Phase 2 clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19 | 2021-11-15 | due-trials |
Ongoing | 2021-000130-33 | A pilot study to explore safety, tolerability and efficacy of ORal IrON supplementation with ferric maltol in treating iron deficiency and anaemia in patients with Heart Failure (ORION-HF) | not-yet-due | |
Ongoing | 2021-005362-18 | Hepatitis B immunoglobulins to induce HBsAg clearance in patients with chronic hepatitis B | not-yet-due | |
Exempt | 2021-006895-17 | Phase Ia/IIb study of PHD inhibitor molidustat in combination with IDH1 inhibitor ivosidenib in IDH1-mutated relapsed/refractory AML or MDS/AML patients | not-yet-due | |
Ongoing | 2022-003526-50 | A prospective, interventional, single-center, single-arm study to assess the effectiveness of Bempedoic acid to achieve LDL-cholesterol targets in patients following ST-elevation or Non-ST-elevation m... | not-yet-due |